Phase 1 Study With OAB Assessing the Safety and Activity of hMaxi-K Gene Transfer

ClinicalTrials.gov ID: NCT01870037

Public ClinicalTrials.gov record NCT01870037. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 23, 2026, 9:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 1 Double Blind, Placebo Controlled Study Assessing Safety and Activity Of 2 Escalating Doses of hMaxi-K Gene Transfer By Direct Injection Into the Bladder Wall In Female Subjects With OAB

Study identification

NCT ID: NCT01870037
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1
Lead sponsor: Urovant Sciences GmbH; Industry
Enrollment: 13 participants

Conditions and interventions

Conditions

Overactive Bladder

Interventions

Placebo (PBS-20% sucrose) Drug
hMaxi-K Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: Female
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 31, 2012
Primary completion: May 31, 2017
Completion: Feb 16, 2018
Last update posted: May 7, 2019

2013 – 2018

United States locations

U.S. sites: 3
U.S. states: 1
U.S. cities: 3

Facility	City	State	ZIP	Site status
AccuMed Research Associates	Garden City	New York	11530	—
NYU	New York	New York	10016	—
Premier Medical Group of the Hudson Valley, PC	Poughkeepsie	New York	12601	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01870037, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 7, 2019 · Synced Jul 23, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01870037 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →